AI Verdict
NASC has stronger fundamentals based on our AI analysis.
NASC vs NAMSW Fundamental Comparison
| Metric | NASC | NAMSW |
|---|---|---|
| Revenue | $656,652.0 | $22.5M |
| Net Income | $-11.5M | $-203.8M |
| Net Margin | -1,744.1% | -905.7% |
| ROE | N/A | -29.8% |
| ROA | -617.0% | -26.5% |
| Current Ratio | 0.14x | 7.88x |
| Debt/Equity | N/A | 0.00x |
| EPS | $-0.22 | $-1.72 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
NASC vs NAMSW: Frequently Asked Questions
Is NASC or NAMSW a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), NASC has stronger fundamentals. NASC is rated STRONG SELL (95% confidence) while NAMSW is rated STRONG SELL (88% confidence). This is not investment advice.
How does NASC compare to NAMSW fundamentally?
Can B Corp has ROE of N/A vs NewAmsterdam Pharma Co N.V.'s -29.8%. Net margins are -1,744.1% vs -905.7% respectively.
Which stock pays higher dividends, NASC or NAMSW?
NASC has a dividend yield of N/A or no dividend while NAMSW has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in NASC or NAMSW for long term?
For long-term investing, consider that NASC has STRONG SELL rating with 95% confidence, while NAMSW has STRONG SELL rating with 88% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about NASC vs NAMSW?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For NASC vs NAMSW, the AI consensus favors NASC based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.